drugset / Trial / NCT06161805

Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study

NCT06161805

Phase 3 Recruiting 56 enrolled Reinier de Graaf Groep
RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this randomized controlled trial is to investigate the effect of esketamine versus placebo on the NRS score for chronic pelvic pain. Secondary endpoints are to assess pain scores, side-effects, quality of life, depressive symptoms and pain coping.

Timeline

Start
2024-03-01
Primary completion
2026-01-01
Completion
2026-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.5 mg/kg Other